Dr. Dunlop has served as Director of the Mood and Anxiety Disorders Program since 2006. He graduated from Mayo Medical School in 1997 and completed Psychiatric Residency training at Emory University in 2001, receiving Board certification in 2002. His clinical and research expertise is in the biology and treatment of major depression and anxiety disorders. He has served as an investigator for more than 50 studies of mood and anxiety disorders, including major depressive disorder, bipolar disorder, PTSD, OCD, generalized anxiety disorder, panic disorder and social phobia . His secondary research interests include the ethics of clinical research and the biology of decision-making and choice behavior.
Dr. Dunlop is also the course director for the mood and anxiety disorders lecture series for the Emory Psychiatry Residency. He provides supervision in psychodynamic psychotherapy for Emory residents and lectures to Emory medical students.Curriculum Vitae
Dr. Rakofsky is a staff physician in the Mood and Anxiety Disorders program. He graduated from the Emory University School of Medicine and completed his psychiatric training in the Department of Psychiatry and Behavioral Sciences at Emory University. He has also received additional training in psychopharmacology and clinical trials administration. He currently runs the Emory University Bipolar Disorders Clinic in addition to serving as the principal investigator for industry-sponsored clinical trials. His areas of interest include: Bipolar disorder, psychopharmacology, and residency education.
Dr. Garlow is the Medical Director for inpatient mental health services and Chief of Psychiatry at Emory University Hospital. He has been a clinician and investigator in the Mood and Anxiety Disorders Program at Emory since 2003. Dr. Garlow received his MD from the University of Pittsburgh and his PhD in Molecular Biology from Carnegie-Mellon University, as part of their joint MD/PhD program. He received his psychiatry training at Stanford University School of Medicine and completed his neuroscience fellowship at Stanford in the Nancy Pritzker Laboratory of Molecular Neurobiology.
He has been the Principal Investigator and Co-investigator on a variety of basic and clinical neuroscience research projects throughout his time at Emory. His current research includes understanding risk for completed suicide, especially genetic risk, novel screening, and outreach methods for people at risk for suicide (AFSP Interactive Screening Project) and the biology and treatment of mood disorders.
Dr. Garlow has participated in the activities of the Metro Atlanta chapter of the American Foundation for Suicide Prevention (AFSP) since the chapter was founded, first as scientific and education chair and now as president. He is a national scientific advisor to AFSP and a member of the steering committee developing the Interactive Screening Project for widespread implementation.